参考文献/References:
[1] Edvinsson L, Haanes KA, Warfvinge K, et al. CGRP as the target of new migraine therapies - successful translation from bench to clinic[J]. Nat Rev Neurol, 2018, 14(6): 338-350.
[2] Scher A, Wang SJ, Katsarava Z, et al. Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes(CaMEO)Study[J]. Cephalalgia, 2019, 39(2): 296-305.
[3] 林燕,张文武,陈涛,等.偏头痛患者脑血管病一级预防证据评价[J].中国现代神经疾病杂志,2015,15(1):33-38.
[4] Chen SP, Qin T, Seidel JL, et al. Inhibition of the P2X7-PANX1 complex suppresses spreading depolarization and neuroinflammation[J]. Brain, 2017, 140(6): 1643-1656.
[5] Nowodworska A, Van Den Maagdenberg A, Nistri A, et al. In situ imaging reveals properties of purinergic signalling in trigeminal sensory ganglia in vitro[J]. Purinergic Signal, 2017, 13(4): 511-520.
[6] 邓兆旭,廖德华,江沛,等.多柔比星对大鼠抑郁样行为及海马内NRG1/ErbB信号通路的影响[J].中南药学,2017,15(7):898-902.
[7] Schneider S, G?z K, Birchmeier C, et al. Neuregulin-1 mutant mice indicate motor and sensory deficits, indeed few references for schizophrenia endophenotype model[J]. Behav Brain Res, 2017, 322(Pt A): 177-185.
[8] Rong G, Ji MH, Gao DP, et al. Neuroinflammation-Induced downregulation of hippocampacal neuregulin 1-ErbB4 signaling in the parvalbumin interneurons might contribute to cognitive impairment in a mouse model of Sepsis-Associated encephalopathy[J]. Inflammation, 2017, 40(2): 387-400.
[9] Zhou F, Xia ZY, Liu K, et al. Exogenous neuregulin-1 attenuates STZ-induced diabetic peripheral neuropathic pain in rats[J]. Acta Cir Bras, 2017, 32(1): 28-37.
[10] 刘洁,李利民,宁楠,等.半夏泻心汤介导的cAMP/PKA信号通路对偏头痛模型大鼠c-fos/c-jun基因的调控作用[J].中药药理与临床,2019,35(3):37-40.
[11] 孔荆荆,来欣,魏雅念,等.神经调节蛋白-1对心肌梗死大鼠心脏交感神经重构的保护效应研究[J].疑难病杂志,2017,16(6):614-617.
[12] Andreou AP, Trimboli M, Al-Kaisy A, et al. Prospective real-world analysis of OnabotulinumtoxinA in chronic migraine post-National Institute for Health and Care Excellence UK technology appraisal[J]. European Journal of Neurology, 2018, 25(8): 1e83-1069.
[13] Karsan N, Palethorpe D, Rattanawong W, et al. Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK[J]. European Journal of Neurology, 2018, 25(6): 811-817.
[14] Wei H, Long T, Qi P, et al. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model[J]. J Neuroinflammation, 2019, 16(1): 78-94.
[15] Choi BM, Lee SH, An SM, et al. The time-course and RNA interference of TNF-α, IL-6, and IL-1β expression on neuropathic pain induced by L5 spinal nerve transection in rats[J]. Korean J Anesthesiol, 2015, 68(2): 159-169.
[16] Ramachandran R. Neurogenic inflammation and its role in migraine[J]. Semin Immunopathol, 2018, 40(3): 301-314.
[17] Abdolahi M, Tafakhori A, Togha M, et al. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor(TNF)-α gene expression and serum level in migraine patients[J]. Immunogenetics, 2017, 69(6): 371-378.
[18] Wang F, He Q, Ren Z, et al. Association of serum levels of intercellular adhesion molecule-1 and interleukin-6 with migraine[J]. Neurol Sci, 2015, 36(4): 535-540.
[19] Ryzhov S, Matafonov A, Galindo CL, et al. ERBB signaling attenuates proinflammatory activation of nonclassical monocytes[J]. Am J Physiol Heart Circ Physiol, 2017, 312(5): H907-H918.
[20] Alizadeh A, Dyck SM, Kataria H, et al. Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury[J]. Glia, 2017, 65(7): 1152-1175.